BioLight Life Sciences Ltd (BOLT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.137x

Based on the latest financial reports, BioLight Life Sciences Ltd (BOLT) has a cash flow conversion efficiency ratio of -0.137x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-5.49 Million ≈ $-14.72K USD) by net assets (ILA40.17 Million ≈ $107.70K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View BOLT share price today for real-time trading data and today's change.

BioLight Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how BioLight Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see BOLT stock market capitalisation for the company's overall valuation and market capitalisation.

BioLight Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioLight Life Sciences Ltd ranked by their cash flow conversion efficiency. Also see how large is BioLight Life Sciences Ltd's balance sheet for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
Silynxcom Ltd. NYSE MKT:SYNX	-0.329x
Agri-Tech (India) Limited NSE:AGRITECH	-0.010x
Bluefield Solar Income Fund LSE:BSIF	-0.001x
Bulletin Resources Ltd AU:BNR	-0.046x
Nala Digital Commerce Ltd TA:SEFA	0.343x
Teuza A Fairchild Technology Venture Ltd TA:TUZA	-0.007x
Shanghai Taihe Water Environmental Technology Development Co Ltd SHG:605081	-0.031x
InZinc Mining Ltd V:IZN	-0.073x

Annual Cash Flow Conversion Efficiency for BioLight Life Sciences Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of BioLight Life Sciences Ltd from 2012 to 2025. Review BioLight Life Sciences Ltd (BOLT) financial flexibility to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA40.17 Million ≈ $107.70K	ILA-10.85 Million ≈ $-29.10K	-0.270x	+24.45%
2024-12-31	ILA30.74 Million ≈ $82.42K	ILA-10.99 Million ≈ $-29.47K	-0.358x	-13.15%
2023-12-31	ILA30.30 Million ≈ $81.24K	ILA-9.58 Million ≈ $-25.68K	-0.316x	-77.88%
2022-12-31	ILA53.69 Million ≈ $143.95K	ILA-9.54 Million ≈ $-25.58K	-0.178x	-8.84%
2021-12-31	ILA61.42 Million ≈ $164.66K	ILA-10.03 Million ≈ $-26.88K	-0.163x	+13.89%
2020-12-31	ILA60.11 Million ≈ $161.14K	ILA-11.39 Million ≈ $-30.55K	-0.190x	+15.87%
2019-12-31	ILA68.15 Million ≈ $182.70K	ILA-15.36 Million ≈ $-41.17K	-0.225x	+21.70%
2018-12-31	ILA77.80 Million ≈ $208.57K	ILA-22.39 Million ≈ $-60.03K	-0.288x	+90.87%
2017-12-31	ILA8.03 Million ≈ $21.53K	ILA-25.32 Million ≈ $-67.88K	-3.153x	-92.02%
2016-12-31	ILA16.41 Million ≈ $43.99K	ILA-26.94 Million ≈ $-72.23K	-1.642x	-221.44%
2015-12-31	ILA47.06 Million ≈ $126.17K	ILA-24.04 Million ≈ $-64.44K	-0.511x	+51.29%
2014-12-31	ILA25.74 Million ≈ $69.00K	ILA-26.99 Million ≈ $-72.35K	-1.049x	+11.60%
2013-12-31	ILA22.11 Million ≈ $59.27K	ILA-26.23 Million ≈ $-70.31K	-1.186x	-127.59%
2012-12-31	ILA37.34 Million ≈ $100.10K	ILA-19.46 Million ≈ $-52.17K	-0.521x	--

About BioLight Life Sciences Ltd

TA:BOLT Israel Biotechnology

Market Cap

$6.63 Million

ILA2.47 Billion ILA

Market Cap Rank

#28087 Global

#402 in Israel

Share Price

ILA273.50

Change (1 day)

-1.97%

52-Week Range

ILA217.90 - ILA542.10

All Time High

ILA3485.66